ArticleFrontiers in pharmacology2025

The RET inhibitor pralsetinib suppresses TMZ-resistant glioma growth by regulating spermine production.

Lingyun Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.